Your browser doesn't support javascript.
loading
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group.
Kwakman, Johannes J M; van Werkhoven, Erik; Simkens, Lieke H J; van Rooijen, Johan M; van de Wouw, Yes A J; Tije, Albert J Ten; Creemers, Geert-Jan M; Hendriks, Mathijs P; Los, Maartje; van Alphen, Robbert J; Polée, Marco B; Muller, Erik W; van der Velden, Ankie M T; van Voorthuizen, Theo; Koopman, Miriam; Mol, Linda; Punt, Cornelis J A.
Afiliação
  • Kwakman JJM; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Electronic address: j.j.kwakman@amc.uva.nl.
  • van Werkhoven E; Department of Biometrics, The Netherlands Cancer Institute (NKI), Amsterdam, the Netherlands.
  • Simkens LHJ; Department of Medical Oncology, Maxima Medical Center, Eindhoven, the Netherlands.
  • van Rooijen JM; Department of Medical Oncology, Martini Hospital, Groningen, the Netherlands.
  • van de Wouw YAJ; Department of Medical Oncology, VieCuri Medical Center, Venlo, the Netherlands.
  • Tije AJT; Department of Medical Oncology, Amphia Hospital, Breda, the Netherlands.
  • Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.
  • Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands.
  • Los M; Department of Medical Oncology, Sint Antonius Hospital, Nieuwegein, the Netherlands.
  • van Alphen RJ; Department of Medical Oncology, TweeSteden Hospital, Tilburg, the Netherlands.
  • Polée MB; Department of Medical Oncology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
  • Muller EW; Department of Medical Oncology, Slingeland Hospital, Doetinchem, the Netherlands.
  • van der Velden AMT; Department of Medical Oncology, Tergooi Hospital, Hilversum, the Netherlands.
  • van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Arnhem, the Netherlands.
  • Koopman M; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands.
  • Mol L; Clinical Trial Department, Netherlands Comprehensive Cancer Organisation (IKNL), Nijmegen, the Netherlands.
  • Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Clin Colorectal Cancer ; 18(2): e229-e230, 2019 06.
Article em En | MEDLINE | ID: mdl-30782413
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Síndrome Mão-Pé / Capecitabina Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Oxônico / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Tegafur / Síndrome Mão-Pé / Capecitabina Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article